Research map: Dysbiosis-associated bile acids slam the brakes on immune checkpoint therapy

Back to the article

Papers in this map

  1. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors · Bertrand Routy · 2017 · 5713 citations · Cited by this paper
  2. Chronic stress unleashes an intratumor phage-fibroblast-B cell circuit to promote tumor growth · 2026 · Related
  3. Gut microbiota in colorectal cancer development and therapy · Chi Chun Wong · 2023 · 727 citations · Cited by this paper
  4. Bridging clinical gaps in personalized cancer neoantigen vaccines · 2026 · Related
  5. Intestine farnesoid X receptor agonist and the gut microbiota activate G‐protein bile acid receptor‐1 signaling to improve metabolism · Preeti Pathak · 2018 · 567 citations · Cited by this paper
  6. Targeting internalization, resistance, and response: Insights from ICARUS-LUNG01 · 2026 · Related
  7. A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers · Marine Fidelle · 2023 · 241 citations · Cited by this paper
  8. When more target antigen expression is less · 2026 · Related
  9. Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome · Lisa Derosa · 2024 · 190 citations · Cited by this paper
  10. Targeting drug-tolerant persister cells: Let’s bring on the TROPs! · 2026 · Related
  11. Bile acid synthesis impedes tumor-specific T cell responses during liver cancer · Siva Karthik Varanasi · 2025 · 173 citations · Cited by this paper
  12. Dissecting the cellular architecture of breast cancer brain metastases reveals prognostically distinct immune landscapes · 2026 · Related
  13. Antibiotic use and gut microbiome composition links from individual-level prescription data of 14,979 individuals · Gabriel Baldanzi · 2026 · 30 citations · Cited by this paper
  14. Context dependency in cancer neuroscience · 2026 · Related
  15. Reliable detection of Host-Microbe Signatures in cancer using PRISM · Bassel Ghaddar · 2026 · 11 citations · Cited by this paper
  16. A conserved re-epithelialization program underlies malignancy in pancreatic ductal adenocarcinoma · 2026 · Related
  17. Intestinal-restricted farnesoid X receptor agonist Fex3 alleviates cholestatic liver injury via FGF15-CYP7A1 axis · Jiangzhou Song · 2026 · 2 citations · Cited by this paper
  18. Mapping cell type-resolved transcriptomic profiles to patient survival in pancreatic cancer · 2026 · Related

Source: OpenAlex (CC0)